drugset / Trial / NCT03131167
Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Safety and tolerability of three different concentrations (0.1%, 03%, 0.6%) of the investigational SHP639 eye drops will be evaluated in participants with high eye pressure or primary open-angle glaucoma.
Timeline
- Start
- 2017-05-10
- Primary completion
- 2018-05-30
- Completion
- 2018-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHP639 | Peptide | 0.1 % | Topical |
| Subject | SHP639 | Peptide | 0.3 % | Topical |
| Subject | SHP639 | Peptide | 0.6 % | Topical |